Patent details

88260 Product Name: TRITACE (Ramipril)

Basic Information

Publication number:
88260
Type:
SPC
SPC Type:
Medical
Basic Patent Number:
EP821100708
Legal Status:
Expired
Application number:
88260
First applicant's nationality:
Procedural language:
French

Marketing Authorization

1

Marketing Authorization Number:
416/90/06/0405
Marketing Authorization Type:
Marketing Authorization Date:
22/06/1990
Marketing Authorization Status:
Accepted
Marketing Authorization Country:
Luxembourg (LU)

2

Marketing Authorization Number:
NL- 15 556
Marketing Authorization Type:
Marketing Authorization Date:
10/01/1989
Marketing Authorization Status:
Accepted
Marketing Authorization Country:

Dates

Filing date:
05/05/1993
First Marketing Authorization date:
10/01/1989
Grant date:
03/02/1994
Activation date:
02/11/2002
Publication date:
03/02/1994
Lapsed date:
Expiration date:
Renunciation date:
Revocation date:
Annulment date:
Basic SPC Expiration:
10/01/2004
SPC Extension Expiration:
10/01/2004
Rejection date:
Withdrawal date:

Owner

From:
07/03/2001
 
 

Name:
AVENTIS PHARMA DEUTSCHLAND GMBH
Address:
BRÜNINGSTRASSE 50, 65929, FRANKFURT, Germany (DE)

History of Owners

From:
05/05/1993
To:
06/03/2001

Name:
HOECHST AKTIENGESELLSCHAFT
Address:
BrÜningstrasse 50, 65929 Frankfurt am Main, Germany (DE)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
05/05/1993
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:
Filing date Document type Number of pages